| Strain and gender differences in the behavior of mouse lines commonly used in transgenic studies V Võikar, S Kõks, E Vasar, H Rauvala Physiology & behavior 72 (1-2), 271-281, 2001 | 481 | 2001 |
| Long‐term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences V Voikar, A Polus, E Vasar, H Rauvala Genes, Brain and Behavior 4 (4), 240-252, 2005 | 406 | 2005 |
| CCK in animal and human research on anxiety J Harro, E Vasar, J Bradwejn Trends in Pharmacological Sciences 14 (6), 244-249, 1993 | 338 | 1993 |
| Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens V Voikar, E Vasar, H Rauvala Genes, Brain and Behavior 3 (1), 27-38, 2004 | 235 | 2004 |
| Antidepressant-and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice V Volke, G Wegener, M Bourin, E Vasar Behavioural brain research 140 (1-2), 141-147, 2003 | 194 | 2003 |
| Evaluation of viscoelastic parameters of the skeletal muscles in junior triathletes G Gavronski, A Veraksitš, E Vasar, J Maaroos Physiological Measurement 28 (6), 625, 2007 | 189 | 2007 |
| 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety V Volke, A Soosaar, S Ko˜ ks, M Bourin, PT Männistö, E Vasar Psychopharmacology 131, 399-405, 1997 | 162 | 1997 |
| Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics J Harro, RA Kiivet, A Lang, E Vasar Behavioural brain research 39 (1), 63-71, 1990 | 139 | 1990 |
| Role of mitochondrial dynamics in neuronal development: mechanism for Wolfram syndrome M Cagalinec, M Liiv, Z Hodurova, MA Hickey, A Vaarmann, M Mandel, ... PLoS biology 14 (7), e1002511, 2016 | 121 | 2016 |
| Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat J Harro, E Vasar European journal of pharmacology 193 (3), 379-381, 1991 | 118 | 1991 |
| Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment J Harro, M Põld, E Vasar Naunyn-Schmiedeberg's archives of pharmacology 341, 62-67, 1990 | 118 | 1990 |
| Association study of 90 candidate gene polymorphisms in panic disorder E Maron, T Nikopensius, S Koks, S Altmäe, E Heinaste, K Vabrit, ... Psychiatric genetics 15 (1), 17-24, 2005 | 111 | 2005 |
| Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder. J Shlik, A Aluoja, V Vasar, E Vasar, T Podar, J Bradwejn Journal of Psychiatry and Neuroscience 22 (5), 332, 1997 | 109 | 1997 |
| Impaired exploratory behaviour after DSP-4 treatment in rats: implications for the increased anxiety after noradrenergic denervation J Harro, L Oreland, E Vasar, J Bradwejn European Neuropsychopharmacology 5 (4), 447-455, 1995 | 102 | 1995 |
| Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze V Volke, S Kõks, E Vasar, M Bourin, J Bradwejn, PT Männistö Neuroreport 6 (10), 1413-1416, 1995 | 102 | 1995 |
| Behavioural differences between C57BL/6 and 129S6/SvEv strains are reinforced by environmental enrichment U Abramov, T Puussaar, S Raud, K Kurrikoff, E Vasar Neuroscience letters 443 (3), 223-227, 2008 | 100 | 2008 |
| Distribution of Wfs1 protein in the central nervous system of the mouse and its relation to clinical symptoms of the Wolfram syndrome H Luuk, S Koks, M Plaas, J Hannibal, JF Rehfeld, E Vasar Journal of Comparative Neurology 509 (6), 642-660, 2008 | 98 | 2008 |
| Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain J Harro, A Lang, E Vasar European journal of pharmacology 180 (1), 77-83, 1990 | 93 | 1990 |
| Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis S Koks, K Kingo, K Vabrit, R Rätsep, M Karelson, H Silm, E Vasar Genes & Immunity 6 (5), 407-415, 2005 | 87 | 2005 |
| IL-10 promoter polymorphisms influence disease severity and course in psoriasis K Kingo, S Koks, H Silm, E Vasar Genes & Immunity 4 (6), 455-457, 2003 | 85 | 2003 |
Sulev KoksprofessorZweryfikowany adres z murdoch.edu.au
